Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Topic Nomination

Issuances

preliminary recommendation for the non-inclusion of eribulin in the treatment of soft tissue sarcoma in the PNF

June 15, 2022

[DEPARTMENT CIRCULAR NO. 2022- 2048] Creation of a Screening Committee for the Appointment of Health Technology Assessment Committee (HTAC) Members

June 13, 2022

[DEPARTMENT CIRCULAR NO. 2022- 0288] Nomination to the Health Technology Assessment Council (HTAC) Social Anthropologist Core Committee Member

June 10, 2022

[DEPARTMENT CIRCULAR NO. 2022- 0291] Health Technology Assessment Council (HTAC) Recommendation to include Potassium Citrate 15 mEq Extended Release (ER) Tablet in the Philippine National Formulary

June 6, 2022

[DEPARTMENT CIRCULAR NO. 2022- 0289] Health Technology Assessment Council (HTAC) Recommendation to include Tocilizumab in the Philippine National Formulary

June 1, 2022

[DEPARTMENT CIRCULAR NO. 2022- 0257] Changes to the Topic Nomination and Appeals Processes of the Philippine HTA Process Guide

May 27, 2022

[DEPARTMENT CIRCULAR NO. 2022- 0254] Updates on the HTAC processing of Minor Inclusion Application

May 20, 2022

[DEPARTMENT PERSONNEL ORDER NO. 2022- 2780 – A] Amendment to the Department Personnel Order No. 2021-2780 entitled “Creation of the pool of clinical experts for consultation on the evaluation of assessment topics” to include Expert Advisory Committee as additional experts

May 17, 2022

[DEPARTMENT PERSONNEL ORDER NO. 2022- 1245] Appointment of the New Member of the Health Technology Assessment Council Subcommittee on Drugs

May 10, 2022

preliminary recommendation for the inclusion of Potassium Citrate 1620 mg (15 mEq) tablet in the PNF.

April 13, 2022

Posts navigation

    • 1
    • 2
    • …
    • 7
  • Older Older
654939
Users Today : 419
This Month : 19735
Total Users : 654939
Your IP Address : 18.232.177.219
Philippine Standard Time: